State Administration of Ukraine on Medicinal Products permitted Farmak JSC to resume manufacturing of the medicinal products

State Administration of Ukraine on Medicinal Products (SAUMP) permitted Farmak JSC to resume manufacturing of the medicinal products, based on the Order No 1810 dated 30 December 2013.

According to the Order issued by SAUMP, it is permitted to resume manufacturing of the following medicinal products:

• PINOSOL®, nasal spray, solution 10 mL per vial № 1 in set with a pump dispenser with nasal spray (Registration Certificate No UA/6606/01/01);
• URONEPHRON®, gel, 100 g per package in tubes (Registration Certificate No UA/11226/01/01);
• CORVALOL®, oral drops, 25 ml, 50 ml per vial № 1 (Registration Certificate No UA/2554/01/01);
• CORVALOL® N, oral drops, 25 ml per vial, № 1 in package (Registration Certificate No UA/3684/01/01);
• CORVALDIN®, oral drops, 25 ml or 50 ml per vial (Registration Certificate No UA/2553/01/01);
• CORVALOL®, tablets № 10×1, № 10×3, № 10×5 packed in blisters (Registration Certificate No UA/2554/02/01);
• FLENOX®, solution for injections, 10000 anti-Ха IU 0,2ml (2000 anti-Ха IU) or 0,4 ml (4000 anti-Ха IU) or 0,6 ml (6000 anti-Ха IU) in syringe; 1 syringe per blister; 1, 2 or 10 blisters per cardboard package; 0,2 ml (2000 anti-Ха IU) or 0,4 ml (4000 anti-Ха IU) or 0,6 ml (6000 anti-Ха IU) in syringe; 2 syringes per blister; 1 or 5 blisters per cardboard package; 0,8 ml (8000 anti-Ха IU) in syringe; 1 syringe per blister; 1 or 2 blisters per cardboard package; 0,8 ml (8000 anti-Ха IU) in syringe; 2 syringes per blister; 1 blister per cardboard package (Registration Certificate No UA/13119/01/01);
• FLENOX®, solution for injections, 10000 anti-Ха IU 0,2ml (2000 anti-Ха IU) or 0,4 ml (4000 anti-Ха IU) or 0,6 ml (6000 anti-Ха IU) in syringe; 1 syringe per blister; 1, 2 or 10 blisters per cardboard package; 0,2 ml (2000 anti-Ха IU) or 0,4 ml (4000 anti-Ха IU) or 0,6 ml (6000 anti-Ха IU) in syringe; 2 syringes per blister; 1 or 5 blisters per cardboard package; 0,8 ml (8000 anti-Ха IU) in syringe; 1 syringe per blister; 1 or 2 blisters per cardboard package; 0,8 ml (8000 anti-Ха IU) in syringe; 2 syringes per blister; 1 blister per cardboard package (packed in-bulk of the production company Hangzhou Jiuyuan Gene Engineering Co., Ltd., China) (Registration Certificate No UA/9353/01/01);
• NAZOFERON®, nasal drops 100 000 MO/ml, 5 ml per glass vial № 1 (Registration Certificate No 657/11-300200000);
• NAZOFERON®, nasal spray 100 000 MO/ml, 5 ml per glass vial № 1 (Registration Certificate No 862/11-300200000).

More news

The best CEOs of Ukraine according to Forbes

Forbes included CEO of Farmak Volodymyr Kostiuk to the rating of the best directors of Ukraine. Twelve years ago, Volodymyr started his career at Farmak as Assistant to General Director, later he held a position in the Finance Division, worked on the SAP system, and in 2018 became the Company’s CEO. Due to the implemented […]

Dec 18, 2020

Sector X: Farmak and a group of angel investors will in...

In February 2020, the acceleration hub Sector X based on UNIT.City announced the opening of 3 tracks (MedTech, Logistics and BeautyTech) with strong corporate partners: pharmaceutical giant Farmak, top retailer of household appliances and electronics Foxtrot and leader in the beauty industry L’Oréal. 11 months of the companies’ work with the startups o...

Dec 09, 2020

Farmak is one of TOP 50 best companies of Ukraine

The Vlast Deneg (The Power of Money) magazine published a rating of Ukrainian companies that adhere to the highest standards of modern European business and make a significant contribution to the development of Ukraine’s economy. The experts selected among 200 applicants those companies that, despite the crisis, quickly adapted to changing conditions, achiev...

Dec 09, 2020